Self-management of Sedative Therapy by Ventilated Patients
Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized clinical trial is to test the efficacy of dexmedetomidine for
the self-management of sedative therapy (SMST) in a sample of critically ill patients
receiving mechanical ventilator support. The investigators hypothesis is that self-management
of sedative therapy by mechanically ventilated patients in the intensive care unit (ICU),
tailored to their individual needs will be more efficacious than nurse-administered sedative
therapy in reducing anxiety, which may reduce duration of mechanical ventilator support and
occurrence of delirium.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) University of Minnesota University of Minnesota, MN